Form 4: Pluri Inc. Insider Transactions: Weinstein Acquires Shares
Statement of Changes in Beneficial Ownership
Alexandre Weinstein, a Director and 10% owner of Pluri Inc., reports significant acquisitions of common stock and warrants through Chutzpah Holdings LP.
Summary
- Alexandre Weinstein, a Director and 10% owner of Pluri Inc. (PLUR), has reported transactions involving the acquisition of common stock and warrants through Chutzpah Holdings LP (CHLP).
- On March 31, 2026, CHLP acquired 312,500 common shares and warrants to purchase an additional 312,500 common shares at a combined price of $4.00 per share and warrant.
- On April 21, 2026, CHLP acquired another 312,500 common shares and warrants to purchase 312,500 common shares under similar terms.
- These transactions are part of a larger Securities Purchase Agreement (SPA) with CHLP, which closed with total gross proceeds of $2,500,000.
- Weinstein also holds additional common shares and warrants through other entities, including Chutzpah Holdings Limited and Plantae Bioscience Ltd.
- The filing also details the vesting of restricted stock units (RSUs) for Mr. Weinstein, with 5,643 shares vested and 641 RSUs scheduled to vest on May 25, 2026.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it confirms a significant capital injection from a key insider, but the details of the transaction and ownership limitations warrant careful consideration.
Positives
- Significant investment by a key insider (Director and 10% owner) in Pluri Inc. common stock and warrants.
- Total gross proceeds of $2,500,000 raised through the private placement with Chutzpah Holdings LP.
- Warrants have anti-dilution provisions and are exercisable, indicating potential for future share acquisition.
- Vesting of RSUs suggests ongoing equity compensation and potential for increased insider ownership.
Negatives
- The transactions are part of a private placement, which may not be indicative of broad market confidence.
- Warrants are subject to a 35% beneficial ownership limitation, restricting the ability to exercise them fully at once.
- Some warrants issued under the December 2025 SPA expire on June 30, 2026, creating a near-term expiration.
Risks
- The 35% beneficial ownership limitation on warrants could restrict the ability of CHLP to exercise its full rights.
- The effectiveness of the company's business strategy and future performance will ultimately determine the value of the acquired shares and warrants.
- The filing does not provide details on the specific use of the $2,500,000 in proceeds, which could be a risk if not allocated effectively.
Future Outlook
The filing primarily reports past transactions and current beneficial ownership. The future outlook is implicitly tied to the exercise of warrants and the vesting of RSUs, which will increase the beneficial ownership of Alexandre Weinstein and associated entities, subject to beneficial ownership limitations.
Management Comments
- "The Reporting Persons undertake to report all future transactions on a timely basis."
- "Each of the Reporting Persons expressly disclaims beneficial ownership with respect to any shares of Common Stock of the Issuer, other than the Common Stock of the Issuer owned of record by such Reporting Person."
- "Neither the filing of this statement nor anything herein shall be deemed an admission that any Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or any other purpose, a member of a group with respect to the Issuer or securities of the Issuer."
- "Each Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities."
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The significant acquisition of stock and warrants by a director and 10% owner like Alexandre Weinstein, through affiliated entities, indicates a strong conviction in the company's prospects or a strategic accumulation of shares. The details of the private placement and associated warrants are crucial for understanding potential future dilution and ownership structure.
Comparison to Industry Standards
- The structure of the transaction, involving common shares and warrants at a combined price, is a common method for private placements in the biotechnology and technology sectors, where Pluri Inc. operates.
- The exercise price of $4.25 for warrants is typical for such placements, often set at a premium to the concurrent share price.
- The 18-month expiration for the warrants is a standard term, balancing the company's need for capital with the investor's timeframe for potential returns.
- The beneficial ownership limitation of 35% is a common feature in private placements to prevent a single investor from gaining excessive control without further corporate action or shareholder approval.
Related Party Transactions
- The transactions involve Chutzpah Holdings LP, Chutzpah Holdings Limited, Plantae Bioscience Ltd., and Mr. Alexandre Weinstein, all of whom are related parties or entities beneficially owned by Mr. Weinstein.
- The company entered into a Securities Purchase Agreement with Chutzpah Holdings LP for the private placement of common shares and warrants.
Stakeholder Impact
- Shareholders: Potential for future dilution if warrants are exercised, but also potential for increased company value if capital is used effectively. The 35% ownership limitation may prevent excessive concentration of voting power by one entity.
- Management: Confirms continued investment and commitment from a key director and significant owner.
- Creditors: The capital raise could strengthen the company's financial position, potentially benefiting creditors.
Next Steps
- Monitoring the exercise of warrants by Chutzpah Holdings LP, subject to beneficial ownership limitations.
- Observing the vesting of remaining restricted stock units for Mr. Weinstein.
- Tracking the company's use of the $2,500,000 in proceeds raised from the private placement.
Key Dates
| Date | Description |
|---|---|
| 12/08/2025 | Date of Securities Purchase Agreement (December 2025 SPA) under which CHLP acquired common shares and warrants. |
| 12/30/2025 | Closing date for the December 2025 SPA. |
| 01/05/2026 | Date of Form 4 filing related to the December 2025 SPA. |
| 02/05/2025 | Date of issuance for warrants held by Chutzpah Holdings LP with an exercise price of $5.568. |
| 03/24/2026 | Date Pluri Inc. entered into the Securities Purchase Agreement (March 2026 SPA) with Chutzpah Holdings LP. |
| 03/31/2026 | First closing date under the March 2026 SPA, where CHLP acquired 312,500 common shares and warrants. |
| 04/02/2026 | Required reporting deadline for the March 31, 2026 transaction. |
| 04/21/2026 | Second closing date under the March 2026 SPA, where CHLP acquired 312,500 common shares and warrants. |
| 05/04/2026 | Date of signatures on the Form 4 filing. |
| 05/25/2026 | Scheduled vesting date for 641 restricted stock units for Mr. Weinstein. |
| 06/30/2026 | Expiration date for common warrants issued under the December 2025 SPA. |
| 09/30/2027 | Approximate expiration date for warrants issued at the March 31, 2026 closing under the March 2026 SPA. |
| 10/21/2027 | Expiration date for warrants issued at the April 21, 2026 closing under the March 2026 SPA. |
| 02/05/2028 | Expiration date for warrants issued on February 5, 2025, with an exercise price of $5.568. |
Recommendation
holdThe filing details a significant capital raise from a key insider, which is generally positive. However, the presence of warrant expirations, beneficial ownership limitations, and the lack of detailed use of proceeds warrant a cautious 'hold' recommendation until further clarity on the company's strategic deployment of capital and future performance is available.
Keywords
Pluri Inc., PLUR, Form 4, Insider Trading, Beneficial Ownership, Securities Purchase Agreement, Common Stock, Warrants, Alexandre Weinstein, Chutzpah Holdings LP, Private Placement, Restricted Stock Units, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.